Literature DB >> 21903273

Vibrio vulnificus IlpA induces MAPK-mediated cytokine production via TLR1/2 activation in THP-1 cells, a human monocytic cell line.

Na Yeon Lee1, Hye-Yeon Lee, Kyu-Ho Lee, Seung Hyun Han, Soon-Jung Park.   

Abstract

Vibrio vulnificus is a pathogenic bacterium causing primary septicemia, which is followed by a classical septic shock pathway including an overwhelming inflammatory cytokine response. V. vulnificus IlpA is a potent immunogenic lipoprotein that triggers cytokine production in human monocytes by activating the toll-like receptor 2 (TLR2). In this study, we further defined the IlpA signaling pathways involved in cytokine production in the human monocytic cell line, THP-1. TLR2 was involved in cytokine production by complexing with TLR1, but not with TLR6. MyD88 was necessary for IlpA-induced cytokine expression through TLR1/TLR2. Three mitogen activated protein kinases (MAPK), p38, ERK1/2, and JNK, were activated in THP-1 cells stimulated with recombinant IlpA (rIlpA). Selective inhibition of each MAPK resulted in significant decrease of rIlpA-induced cytokine production. Especially, functional TLR2 was necessary for IlpA-induced activation of p38 and JNK. IlpA augmented the DNA-binding activity of nuclear factor-kappaB (NF-κB) and activator protein-1 (AP-1) transcriptional factors to their recognition sites in THP-1 cells. These results suggest that serial activation of TLR1/TLR2, MyD88, the three MAPKs, and NF-κB/AP-1 comprises the signaling pathway responsible for proinflammatory cytokine production by V. vulnificus IlpA.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21903273     DOI: 10.1016/j.molimm.2011.08.001

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  7 in total

1.  Neutrophils are essential for containment of Vibrio cholerae to the intestine during the proinflammatory phase of infection.

Authors:  Jessica Queen; Karla J Fullner Satchell
Journal:  Infect Immun       Date:  2012-05-21       Impact factor: 3.441

Review 2.  Epidemiology, pathogenetic mechanism, clinical characteristics, and treatment of Vibrio vulnificus infection: a case report and literature review.

Authors:  Fei Leng; Shilong Lin; Wei Wu; Jincheng Zhang; Jieqiong Song; Ming Zhong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-07-19       Impact factor: 3.267

3.  Identification of Novel Inflammatory Cytokines and Contribution of Keratinocyte-Derived Chemokine to Inflammation in Response to Vibrio vulnificus Infection in Mice.

Authors:  Xiao-Fei Liu; Jing Wu; Ming-Yi Wang; Ying-Jian Chen; Yuan Cao; Cheng-Jin Hu
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

4.  TLR2 and TLR4 mediate the TNFα response to Vibrio vulnificus biotype 1.

Authors:  Lola V Stamm; Rebecca L Drapp
Journal:  Pathog Dis       Date:  2014-03-06       Impact factor: 3.166

5.  MARTX toxin of Vibrio vulnificus induces RBC phosphatidylserine exposure that can contribute to thrombosis.

Authors:  Han Young Chung; Yiying Bian; Kyung-Min Lim; Byoung Sik Kim; Sang Ho Choi
Journal:  Nat Commun       Date:  2022-08-17       Impact factor: 17.694

6.  Vibrio vulnificus RtxA Is a Major Factor Driving Inflammatory T Helper Type 17 Cell Responses in vitro and in vivo.

Authors:  Arim Lee; Myun Soo Kim; Daeho Cho; Kyung Ku Jang; Sang Ho Choi; Tae Sung Kim
Journal:  Front Immunol       Date:  2018-09-19       Impact factor: 7.561

7.  Siegesbeckia pubescens Makino inhibits Pam3CSK4-induced inflammation in RAW 264.7 macrophages through suppressing TLR1/TLR2-mediated NF-κB activation.

Authors:  Wei Sang; Zhangfeng Zhong; Kegang Linghu; Wei Xiong; Anfernee Kai Wing Tse; Wai San Cheang; Hua Yu; Yitao Wang
Journal:  Chin Med       Date:  2018-07-05       Impact factor: 5.455

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.